Cover Image

Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Chronic Myelogenous Leukemia at Different Phases of the Disease

Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. Telomerase- essential enzyme that adds telomeric repeats into the telomeres- maintains integrity of chromos...

Full description

Saved in:

Bibliographic Details
Main Authors:	K Alimoghadam (Author), N Eynolahi (Author), Y Mortazavi (Author), Sh Rostami (Author), SH Ghaffari (Author), A Amini (Author), Y Gahani (Author), A Ghavamzadeh (Author)
Format:	Book
Published:	Tehran University of Medical Sciences, 2008-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Human Telomerase Reverse Transcriptase (hTERT) expression in patients with Chronic Myelogenous Leukemia at defferent phases of the disease
by: A Amini, et al.
Published: (2008)

Human telomerase reverse transcriptase expression in ovarian tumors
by: Awadh Ali Makhashen Maraei, et al.
Published: (2012)

Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer
by: Jayanthi Palani, et al.
Published: (2011)

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
by: Qingrong Li, et al.
Published: (2021)

Investigation of P16INK4A and P14RF genes expression in different phase of Chronic Myeloid Leukemia (CML)
by: SH Mousavi, et al.
Published: (2008)

Investigation of P16INK4A and P14RF Genes Expression in Different Phase of Chronic Myeloid Leukemia (CML)
by: SA Mousavi, et al.
Published: (2008)

Impact of Ethinyl Estradiol to Human Telomerase Reverse Transcriptase Activity on Complete Hydatidiform Mole Culture
by: Tatit Nurseta, et al.
Published: (2016)

Homology modeling and docking studies of Plasmodium falciparum telomerase reverse transcriptase with berberine and some of its derivatives
by: Pratap Parida, et al.
Published: (2014)

Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT Locus
by: Kimberly A Wilson, et al.
Published: (2013)

Antiproliferative Effects of Ferulic, Coumaric, and Caffeic Acids in HepG2 Cells by hTERT Downregulation
by: Afsoon Afshari, et al.
Published: (2022)

Alternative Splicing of Human Telomerase Reverse Transcriptase May Not Be Involved in Telomerase Regulation During all-trans-Retinoic Acid-Induced HL-60 Cell Differentiation
by: Wei-Jun Liu, et al.
Published: (2004)

Comparison of Inhibitory Effect of Curcumin Nanoparticles and Free Curcumin in Human Telomerase Reverse Transcriptase Gene Expression in Breast Cancer
by: Nosratollah Zarghami, et al.
Published: (2013)

hTERT-Immortalized Bone Mesenchymal Stromal Cells Expressing Rat Galanin via a Single Tetracycline-Inducible Lentivirus System
by: Ke An, et al.
Published: (2017)

Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders
by: Aline Correa Abrahao, et al.
Published: (2011)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
by: Hasan Afzaal, et al.
Published: (2022)

Generation of a hTERT-Immortalized Human Sertoli Cell Model to Study Transporter Dynamics at the Blood-Testis Barrier
by: Raymond K. Hau, et al.
Published: (2020)

hTERT, BICD1 and Chromosome 18 Polymorphisms Associated with Telomere Length Affect Kidney Allograft Function After Transplantation
by: Karolina Kłoda, et al.
Published: (2015)

Detection of PLZF- RARa fusion in patients with Acute Promyelocytic Leukemia
by: M Araghi, et al.
Published: (2008)

Detection of PLZF- RARa Fusion in Patients with Acute Promyelocytic Leukemia
by: SH Rostami, et al.
Published: (2008)

Inflamm-Aging Is Associated with Lower Plasma PTX3 Concentrations and an Impaired Capacity of PBMCs to Express hTERT following LPS Stimulation
by: Aaron L. Slusher, et al.
Published: (2019)

Porcine somatic cell nuclear transfer using telomerase reverse transcriptase-transfected mesenchymal stem cells reduces apoptosis induced by replicative senescence
by: Ryounghoon Jeon
Published: (2020)

G2/M Checkpoint Abrogation With Selective Inhibitors Results in Increased Chromatid Breaks and Radiosensitization of 82-6 hTERT and RPE Human Cells
by: Aggeliki Nikolakopoulou, et al.
Published: (2021)

The Molecular Docking of Specific Reverse Transcriptase Inhibitory Ligands onto the Molecular Model of HIV-1 Reverse Transcriptase
by: Roohallah Yousefi
Published: (2024)

The proximal promoter region of <it>mTert </it>is sufficient to regulate telomerase activity in ES cells and transgenic animals
by: Pintado Belen, et al.
Published: (2006)

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013)

A case of chronic myelogenous leukemia cutis: A rare presentation
by: U S Kanade, et al.
Published: (2011)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
by: Gopalarethinam Janani, et al.
Published: (2023)

MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression
by: Wenjie Li, et al.
Published: (2022)

The effect of aerobic exercise and omega-3 on the expression of telomeric repeat binding factor 1 and 2 and telomerase reverse transcriptase enzyme in the heart tissue of elderly HFD rats
by: Ghasem Torabi Palat Kaleh, et al.
Published: (2023)

QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
by: R. D. Jawarkar, et al.
Published: (2021)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011)

Deep cutaneous candidiasis of the lip in a patient with acute myelogenous leukemia
by: Jose L. Cortez, MD, MS, et al.
Published: (2022)

Approved HIV reverse transcriptase inhibitors in the past decade
by: Guangdi Li, et al.
Published: (2022)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023)

Disseminated Tuberculous Myositis in a Child with Acute Myelogenous Leukemia
by: Yu-Chieh Chen, et al.
Published: (2009)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011)

Preleukemic phase of chronic myelogenous leukemia: A diagnostic dilemma highlighting the significance of integrated reporting
by: Neelum Mansoor, et al.
Published: (2023)

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia: Some observations
by: Mayur Parihar, et al.
Published: (2014)

Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review
by: Elżbieta Bartoszewska, et al.
Published: (2024)

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia - accelerated phase: A rare case with review of the literature
by: Narender Kumar, et al.
Published: (2013)